Investing.com -- Walmart Inc (NASDAQ:WMT) plans to cover more than 250 prescription medications at no cost for its workforce, according to a staff memo from Chief People Officer Donna Morris reported by Bloomberg. The expansion includes popular diabetes treatments like Novo Nordisk's Ozempic and Eli Lilly's Mounjaro for employees with Type 2 diabetes, subject to prior approval. Before you buy NVIDIA: our AI model's stock picks are beating the market by 120%+. See the list now » The initiative comes as corporate America faces escalating medical expenses, prompting many peer organizations to scale back benefits or eliminate GLP-1 drug coverage entirely.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.